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SIX TESTS FOR CARCINOGENICITY
APPENDIX IV
THE DEGRANULATION TEST
P. A. LEFEVRE
ONE of the first morphological lesions
seen in the secretory organs ofthe animals
treated with carcinogens is the degranula-
tion of rough endoplasmic reticulum and
the resultant increase in smooth endo-
plasmic reticulum. Degranulation has been
caused by many carcinogens with struc-
tures as diverse as the azo dyes (Porter and
Bruni, 1959; Svoboda and Higginson,
1968; Ketterer et al., 1967), dimethyl- and
diethyl-nitrosamine, ethionine and afla-
toxin B1 (Svoboda and Higginson, 1968)
and 2-acetylaminofluorene (Flaks, 1970).
Williams and Rabin (1969) found that the
degranulation effect could be reproduced
in vitro using an isolated liver rough
endoplasmic reticulum preparation incu-
bated with aflatoxin B1.
The liver provided a good model for the
study ofcarcinogen-induced degranulation
for 2 reasons: firstly it was a rich source
of rough endoplasmic reticulum and
secondly it has the metabolic capacity
required to generate active forms of
carcinogen from precursors. The main
difficulties experienced are in the methods
employed to monitor ribosome loss. Wil-
liams and Rabin (1971) assayed the
rearrangease activity ofmembranes before
andaftertreatmentwithcarcinogen. Asthe
ribosomes were removed, the enzyme was
exposed and its activity estimated. How-
ever, the enzyme assay is a multistage
operation, depending on several para-
meters. Rearrangease catalyses the correct
distribution ofthe disulphide bonds which
maintain the tertiary structure ofproteins.
Therefore, a substrate with its disulphide
bridges in the incorrect positions must be
used for the assay. In practice (Williams
and Rabin, 1971), ribonuclease with
randomly reoxidized disulphide bridges
was used.
A direct method of monitoring ribosome
loss is by estimating RNA/protein ratios
of membranes. This ratio is decreased
in degranulated membranes due to the
loss ofRNA with the ribosomes. However,
accurate RNA determinations are essen-
tial, as the changes in RNA content are
small. The sensitivity of the RNA assay
cannot easily be improved and the analy-
sis takes a considerable length of time.
Because of the inherent difficulties with
the rearrangease assay, the use of mem-
branes containing radiolabelled RNA was
developed (Purchase and Lefevre, 1975).
MATERIALS AND METHODS
General
Buffers were made up as follows.-(a)
0-25M sucrose (Aristar, B.D.H.) in 50 mM
Trizma base (reagent grade, Sigma chemicals)
25 mm KCI and 5 miM mg C12 (0-25M STKM)
and titrated to pH 7-5 with HCI (b) 1-35M
sucrose, with ion concentration and pH as
above (1-35M STKM). (c) 2-OM sucrose, with
ion concentration and pH as above (2-OM
STKM).
Co-factor solution contained in 0-5 ml.-
NADP monosodium salt (Sigma grade,
Sigma chemicals) 1-3 umol; glucose-6-phos-
phate monosodium (Sigma) 20 ,umol; nico-
tinamide (Sigma) 100 /_tmol.
The cofactor solution was made in bulk in
0-25M STKM and stored frozen at - 200C
in 10 ml portions.
Membrane preparation
Six male rats (170-200 g) of the Wistar-
derived Alderley Park strain were starved
for 24 h to deplete pyrmidine precursors.
Each animal was then injected i.p. with
0-5 ml of a solution of [6 - 14C] orotic aid
monohydrate in distilled water (50 ,uCi,
146 ,ug per rat, (The Radiochemical Centre,
Amersham, Bucks). The dosed animals were
fed to stimulate uptake of label and killed
by cervical dislocation 17 h after injection.
This interval is required for effective labelling
of ribosomal RNA, which has a half-life of
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5 days (Loeb et al., 1965). The livers were
removed from the animals, washed in ice-cold
0-25M STKM, cut into small pieces and
homogenized in ice-cold 0-25M STKM (25%
w/v homogenate using 8 passes of a Potter-
Elvehjem homogenizer) running at 1070
rev/min). The homogenate was centrifuged
at 19,000 g in an MSE 18 refrigerated centri-
fuge for 10 min at 4°C. This supernatant
was layered over a sucrose discontinuous
density gradient of 8 ml 20M STKM and
12 ml 1F35M STKM. Centrifugation at
105,000 g for 4-5 h at 4°C in an MSE Super-
speed 50 centrifuge produced a separation of
the smooth and rough endoplasmic reticulum
fraction (SER, RER) at the interfaces. The
membranes were separately removed by
aspiration, diluted 3 X with 0-25M STKM
and pelleted by centrifugation at 105,000 g
(max.) for 1-5 h at 4°C. The membranes
were stored overnight as frozen pellets at
- 70°C. The SER and RER were resus-
pended by adding 8 ml of warmed (45°C)
0-25M STKM to each pellet, using the same
homogenization techniques used for mem-
brane preparation. Warmed buffer was used
in order to thaw the membranes rapidly and
so prevent damage to both membrane struc-
ture and microsomal activity (Fleischer and
Kervina, 1974).
One-ml portions RER containing 5 mg
protein were rapidly frozen with C02/acetone,
in 25 ml conical tubes and stored at - 70°C.
At this temperature the loss of microsomal
enzyme activity is kept to a minimum
(Borton et al., 1974).
Degranulation scheme
RERportionswererapidlythawed. Samples
were made up to 3 ml each by the addition
of 0-25M STKM alone, or the same buffer
containing the components of the generating
system. The test compound, usually dissolved
in dimethyl sulphoxide (DMSO) was added
to the RER at 250C. Control samples con-
tained the requisite volume of solvent alone.
In the case of compounds insoluble in DMSO,
alternative solvents were used, such as water,
DMSO: acetone (5:3 v/v) or DMSO:ethanol
(5:3). Controls were always incubated in the
presence of the relevant solvent mixture.
DMSO was always used, even in the case of
water-soluble compounds, as it appeared to
have a stabilizing effect on the membranes.
The reaction was started with either
enough NADPH (dissolved in 0-25M STKM,
pH 7.5) to give a final concentration of
0 5 mm or 2-5 units of glucose-6-phosphate
dehydrogenase (G6PD, Type XV Sigma) in
the case of incubations using a generating
system. Samples were incubated at 25°C
shaking at 120 cycles/min in a water bath.
After 1 h incubation, either NADPH was
added to bring the concentration to 1I0 mm
or a further 2-5 units of G6PD. The use of
spectral measurements at 340 nm, using an
SP800 spectrophotometer (Unicam) showed
that NADPH was still being produced at
maximum levels after 2 h from this genera-
ting system.
At the end of 2 h total incubation, the
samples were made more viscous by the
addition of 20M STKM to a molarity of
0-7M with respect to sucrose, in order to slow
down membrane sedimentation and so pre-
vent physical trapping of polysomes in the
membranes. The samples were then layered
over a discontinuous density gradient of
3.5 ml 20M STKM and 1D0 ml 1-35M STKM
and centrifuged at 100,000 g for 8 h at 4°C.
The membranes, present in the 1-35M STKM
layer, were removed by aspiration, diluted
with 0-25M STKM and pelleted by centri-
fugation at 200,000 g (max) for 1.5 h. Mem-
brane pellets were stored at - 20°C until
analysis.
Membranes were resuspended in water
(10 ml) by ultrasonication, using an exponen-
tial probe at 10 ,tm amplitude fitted to an
MSE 150-watt ultrasonic disintegrator. Ali-
quots of 0-2 ml were removed for the estima-
tion of radioactivity. The radioactivity
present in the original membranes and
extracts was measured by counting in Insta-
gel (Packard) using an Intertechnique LS30
scintillation counter. Efficiency ofcounting, as
determined by the use ofan internal standard,
was > 90%. Portions were also analysed for
protein, using the Lowry manual (Lowry et
al., 1951) or automated (Gaunce and D'Iorio,
1970) method. The protein and radioactvity
of RER and SER samples were analysed in
the same way.
Ten aliquots of RER were incubated
simultaneously. Controls and tests were
always carried out in duplicate. The specific
activity of membranes (radioactivity/mg
membrane protein) was considered to be an
accurate estimate ofRNA/protein ratio ofthe
membrane. A reduction in RNA/protein
ratio was taken as an index ofdegranulation.
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The specific activity (or RNA/protein
ratio) of the SER establishes the lowest
value that can be reached by totally degranu-
lated RER. The difference between the
specific activity of SER and RER represents
the theoretical maximum degranulation.
Therefore, the difference in values between
test and control incubations can be expressed
as a percentage degranulation caused by a
particular compound.
The criterionforavalid experiment wasthat
the duplicate sampleswereincloseagreement.
Degranulation of5% was considered positive.
The amount of compound used for each
test is shown in the relevant tables. Three
compounds, the polycyclic hydrocarbon 3,4-
benzpyrene and 2 arylamines, N-2-fluorenyl-
acetamide and 3,3'-dichlorobenzidine, were
incubated in varying amounts with RER to
produce dose-response curves.
Specificity of radiolabelling
In early experiments checking the specifi-
city of radiolabelling, RNA was determined
(Fleck and Begg, 1954) to ascertain the
correlation between RNA/protein ratios and
the radiolabelling results. To test the speci-
ficity of RNA radiolabelling, the RNA was
extracted asperchloric-acid-soluble hydrolysis
products, free from contaminating DNA and
protein (Fleck and Begg, 1954) and RNA in
the samples was measured by the method of
Fleck and Begg and the radioactivity meas-
ured as described previously.
To check thattheribosomes were uniformly
radiolabelled, the RNA and radioactivity
content of RER samples were estimated
before and after treatment with 5 mm EDTA.
According to Sabatini et al. (1966) this
process removes most of the small ribosomal
sub-units and some of the large sub-units.
RER, at a concentration of 5 mg protein/ml,
was incubated in 0-25M STKM buffer, pH 7-5,
containing EDTA at a final concentration of
5mM for0*5h at 25°C in ashaking waterbath.
The resultant suspension was layered over a
discontinuous density gradient consisting of
10 ml of 2-OM STKM and 2-0 ml of 1-35M
STKM and centrifuged at 105,000 g (max)
for 4-5 h at 4°C. The 1-35M STKM layer
containing the membranes was removed,
diluted with 0-25M STKM and centrifuged at
105,000 g (max) for 1-5 h to yield a pellet of
RER stripped of ribosomes. RNA and
radioactivity and protein of this stripped
membrane, and of the original RER mem-
brane were analysed as previously described.
RESULTS
Some additional experiments were car-
ried out to examine dose responses and the
effects of metabolism.
Specificity of radiolabelling
Extraction of RNA from membranes
and the determination of radioactivity in
the extract showed that more than 90%
of the label was associated with RNA in
both RER and SER.
TABLE IV.1.-Treatment of RER with
EDTA to Produce Stripped RER
Membrane
type
RER
Stripped RER
SER
RNA
Protein
ratio
0-152
0*073
0*020
Specific activity
(d/s/mg)
Protein RNA
2034 13,390
969 13,269
381 19,106
Table IV.1 shows the results of treating
RER with 5 mm EDTA. There is good
agreement between the 2 methods used
to estimate degranulation, a value of
59.8% being obtained from RNA/protein
ratios, and one of 64.4% by specific-
activity measurements. The specific-acti-
vity values for RNA in RER and stripped
RER are also in good agreement, indica-
ting that the ribosomal RNA is uniformly
radiolabelled.
Table IV.2 shows a comparison between
RNA/protein ratios and specific-activity
measurements on the same membrane
samples incubated with 2 carcinogens.
This confirms the close correlation between
the 2 methods.
Table IV.3 shows the individual results
for all the compounds tested. Using
radioactivity to detect degranulation, %
degranulation > 5% was regarded as a
positive result.
Figure IV.1 shows data obtained incu-
bating varying amounts of 3,3'-dichloro-
benzidine with RER aliquots. The data
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TABLE IV.2.-Effect of Carcinogens on Degranulation as Measured by RNA/Protein
Ratio andSpecific Activity Estimation.
RNA/protein ratio
% Degranulation
Specific activity (d/s/mg protein)
% Degranulation
Control
0-141
1441-0
Diethylnitrosamine
0-128
12*8
1332 -0
10-3
3,4-Benzpyrene
0-115
24-5
1164-0
26*1
TABLE IV.3.
Compound
Acridine
2-Acetylaminofluorene
4-Acetylaminofluorene
Aflatoxin Bj+generating system
-generating system
4-Aminoazobenzene
2-Aminobiphenyl
4-Aminobiphenyl
2-Aminochrysene
6-Aminochrysene
3-Aminopyrene
2-Aminonaphthalene-1-sulphonic
acid
Aniline
p-Anisidine
Anthracene
2-Aminoanthracene
Anthranilic acid
Anthraquinone
Anthrone
1,2-Benzanthracene
Benzanthrone
Benzidine
Benzimidazole
Benzoic acid
3,4-Benzpyrene
6-Benzoyl-2-naphthol
Biphenyl
Bis azo compound
Bis(Chloromethyl)ether
N,N'-Bis(2-naphthyl)-p-
phenylenediamine
Butanesultone
Caffeine
Calmagite
Camphor
Carbazole
Chlorambucil
Chloramine T
Cholesterol
Colchicine
Croton oil
Cyanocobalamin (B 12)
Cycasin acetate
Cyclohexylamine
Cyclophosphamide
3,3'-Diaminobenzidine
2,7-Diaminofluorene
3,4,5,6-Dibenzacridine
1,2,3,4-Dibenzanthracene
3,4,9,10-Dibenzpyrene
3,3'-Dichlorobenzidine
2,4-Dichlorophenoxyaceate
Dicyclohexylamine
Incubate
(.Ug/ml)
12
8*5
815
12
12
12
12
12
17
17
815
12
12
12
8*5
815
12
12
12
815
12
12
12
12
85
12
815
12
12
12
12
12
12
12
12
12
12
12
815
12
12
12
12
12
8-5
8-5
12
8*5
12
12
12
12
Degranulation
(%)
3.5
14-4
9-6
1-3
25*5
8~~~~~ -56
25 -5
8~~~ ~~ -53
1880
15*8
18*1
21-3
8~~~ ~~ -56
2-5
23 -5
14-4
14-5
> 37
4.7
4-0
12-6
21-3
21.7
>2*6
3-5
1524
5.-4
3 42
3.9
47. >2 0
12-3
4*0
2012
3-4
26 -9
3-0
>2 0
2 3
4.4
7.5
>287
6-4
14-2
7-6
11-8
12 -2
8 -2
1 0
9.5
25-7
15-3
>1*0
Carcinogenicity
A
in test in lit.
+ +
+_
_ +
~+
+ +
+ + ± +
+ +
±
±
±
+
+
+
+
+
+
±
±
+
+
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TABLE IV.3-conttnued.
Compound
D.D.T.
Dieldrin
Diethylnitrosamine
Diethylstilboestrol
3,3'-Dimethoxybenzidine
4-Dimethylaminoazobenzene
9,10-Dimethylanthracene
p-Dimethylaminobenzaldehyde
7,9-Dimethylbenzacridine
7,10-Dimethylbenzacridine
9,10-Dimethyl-1,2-benzanthracene
1,1'-Dimethyl-4,4'-bipyridinium
dichloride
3,3'-Dimethylbenzidine
Dimethylcarbamoyl chloride
Dimethylformamide
Dimethylnitrosamine
2,3-Dimethylquinoxaline
Dinitrobenzene
2,4-Dinitrofluorobenzene
2,4-Dinitrophenol
Dinitrosopentamethylene tetramine
DL-Ethionine
1,1'-Ethylene-2,2'-bipyridinium
dibromide
Ethylenethiourea
Ethyl methanesulphonate
Hexachlorocyclohexane
Hexamethylphosphoramide
Hydrazine
Hydrocortisone
Indole
Merchlorethamine
20-Methylcholanthrene
Methylene bis(2-chloroaniline)
2-Methylindole
MNNG
3-Methyl-4-nitroquinoline-N-oxide
Mitomycin C+generating system
-generating system
Morgan's base
Naphthalene
l-Naphthol
2-Naphthol
1-Naphthylamine
2-Naphthylamine
2-Naphthylamine disulphonic acid
Nitrobenzene
2-Nitrobiphenyl
4-Nitrobiphenyl
2-Nitrofluorene
N-Nitrosodiphenylamine
N-Nitrosoephedrine
N-Nitrosofolic acid
4-Nitroquinoline-N-oxide
4-Nonylphenol/ethylene oxide
condensate
Orotic acid
Perylene
Phenobarbital
N-phenyl-2-naphthylamine
Propanesultone
,-Propiolactone
Resorcinol
Incubate
( tg/ml)
12
12
17
12
12
12
12
12
12
12
8-5
12
12
12
12
12
12
12
12
12
12
12
12
12
12
12
12
12
12
12
12
12
12
12
8-5
12
12
12
12
12
12
12
8-5
8-5
12
12
12
12
12
12
12
12
12
12
12
12
12
12
12
17
12
Degranulation
(%)
>1 -5
4.3
26-4
3-2
11-6
14-3
1-3
>2-0
19-3
20-1
13-5
4-1
10-5
3 -5
>0-3
12-7
7-1
0-1
>6-5
6-8
3-1
10-2
1-7
>7-8
4-1
12-4
2-8
>2 -4(c)
4-0
>0-8(c)
>2 -6(c)
19-1
17-9
8-1
19*0
>1-6(c)
>0-4
17-4
3 3
>0-8
>1-3
1-4
9.9
16-4
2-2
4-5
10-5
11-4
17-1
>1-8
9 7
1*1
8-0
>3-6
>5-2
0-0
>0-6
6-5
12-0
17-3
>0-4
Carcinogenicity
in test in lit.
± ±
_ ~+
± ±
+ ±
_ ~+
± ±
+ ±
+ +
±
+
+
+
±
+
+
±
±
+
+
+
±
+
+
+
±
+
+
±
±
+
+
±
+
±
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TABLE IJT.3.-continued.
Complomnid
Riboflavin
Safrole
3,3',5,5'-Tetramethylbenizi(di <e
Toluene
Toluene-2,4-diisocyanate
2,4,5-Trichlorophenoxyacetate
Tirimethylphosphate
Urethane
Vinyl chloridle
Incubate
(Gg/ml)
12
12
12
17
12
12
12
12
.3 17
Degranulat ion
>5.6(
16 8
1f) *-:
>2 7
0.1
>5.8
>3 8
> 8
Calcinogeniicity
in test in lit.
40
t
1o
a 20 h)
0
10.0
*'(2)
i(2
(4)
11'0 3'O
1
5'
nmol 33'DLCB.
per mg RER protein
7T0
Fio;. 1. Effect, of varying concentrations of
3,3'-dichlorobenzicline (3,3' DCB) on the
extent of degranulation of RER. The
points are means of the number of (leter-
minations shown in parentheses; the bars
indicate ranges.
are from several membrane samples, the
concentration of compound being adjusted
to take into account the amount of mem-
brane protein present, and hence the
amount of microsomal enzymes. Dose-
response experiments were also carried
out on further compounds.
DISCUSSION
Experiments reported in the results
confirm that RER membranes prepared
contain uiniiforlmly labelled RNA, anid that
>90%0 of the radioactivity is associated
with RNA. The results thus confirm that
radioactivity can be equated with RNA
content.
Of the 58 carcinogens tested, 41 (71%)
gave a positive result. A correct negative
result was obtained with 44 of 62 non-
carcinogens tested (71%0). The overall pre-
dictive value for all compounds was 7100.
Aflatoxin B1 and mitomycin C both
gave a positive result in the absence of
NADPH, buit a negative result in the
presence of NADPH. The result with
aflatoxin B1 confirms data obtained by
Williams and Rabin (1971). However,
evidence has been reported that aflatoxin
B1 must be metabolized to exert its
carcinogenic effect (Garner, 1973), 2,3-
epoxyaflatoxin B1 being proposed as the
probable reactive compound and therefore
a possible ultimate carcinogen (Garner,
1973; Swenson et al., 1973).
There appears to be no correlation
between extent of degranulation and
carcinogenic potency. For example, afla-
toxin B1, a potent liver carcinogen,
causes less degranulation than 3-amino-
pyrene. Similarly, the test is not specific for
liver carcinogens, compounds as diverse
in action as some polycyclic hydrocarbons
and 2-naphthylamine also giving positive
results.
Some caution is needed wlhen this
work is compared with that of other
laboratories. It is well known that micro-
somal activity against a variety of sub-
strates shows wide variation between rats
of different strains (Page and Vesell,
1969) and age (Shoemaker and Hamrick,
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1974). Differing conditions of husbandry,
and the nutritional state of the animals
also have effects on the cytochrome P450
levels and subsequently on the enzymic
activity of microsomes (Vesell, 1967;
Vesell et al., 1972; Basu and Dickerson,
1974). All these factors could, therefore,
influence the metabolism of carcinogens.
Figure IV.1 illustrates a dose-response
curve for 3,3'-DCB. Similar curves were
obtained using other carcinogens. The
data reflect the care needed in choosing
dose levels in degranulation assays. In-
creasing the carcinogen concentration
aboveacertainlevel decreasesthe degranu-
lation. The concentrations used in the eva-
luation screen were those falling in the
area of maximum degranulation.
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